Aldeyra Therapeutics (ALDX) Shares Issued (2013 - 2026)

Aldeyra Therapeutics' Shares Issued history runs 14 years deep, the most recent figure standing at $10.0 million for Q1 2026.

• Quarterly Shares Issued rose 20.03% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 20.03% YoY) and the FY2025 annual result came in at $8.6 million, up 12.61% from the prior year.
• Shares Issued was $10.0 million for Q1 2026 at Aldeyra Therapeutics, up from $8.6 million in the prior quarter.
• Across five years, Shares Issued topped out at $10.0 million in Q1 2026 and bottomed at $3.3 million in Q3 2022.
• A 5-year average of $6.6 million and a median of $6.4 million in 2023 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2022 — Shares Issued surged 134.49% — and 2024, when it retreated 29.69%.
• Aldeyra Therapeutics' Shares Issued stood at $5.4 million in 2022, then rose by 8.6% to $5.9 million in 2023, then advanced by 29.87% to $7.6 million in 2024, then increased by 12.61% to $8.6 million in 2025, then gained by 16.59% to $10.0 million in 2026.
• Business Quant data shows ALDX's Shares Issued at $10.0 million in Q1 2026, $8.6 million in Q4 2025, and $8.6 million in Q3 2025.